Alloplex Biotherapeutics reported raising $20.7 Million in an initial SEC Form D filing, from an offering of $25 Million
Round Type
Venture
South KoreaBiotechnologyWho else raised in Biotechnology around the same time
Companies in the same sectors as Alloplex Biotherapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Synaptive Medical raised $40M on March 13, 2023.
- Human Longevity raised $11M on March 13, 2023.
- Viridos raised $5M (Funding Round) on March 13, 2023.
- Evergreen Theragnostics raised $15M (Series B) on March 13, 2023.
- Adze Biotechnology raised $6.1M on March 10, 2023.
- Virax Biolabs raised $4M on March 10, 2023.
Who to call at Alloplex Biotherapeutics, Inc., and when
A new round usually means Alloplex Biotherapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Alloplex Biotherapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alloplex Biotherapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alloplex Biotherapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alloplex Biotherapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Alloplex Biotherapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.